MyMD Pharmaceuticals, Inc. entered into a Securities Purchase Agreement with accredited investors to sell preferred stock and warrants, and also entered into an Omnibus Waiver and Amendment with the Required Holders to defer payment and waive breaches. They filed an Amended and Restated Certificate of Designations and increased the number of directors, appointing Mitchell Glass as a board member.